An approach to acute clinical deterioration in patients with late-stage Parkinson's disease.

Aust J Gen Pract

PhD, FRCP, Conjoint Associate Professor, Sydney Medical School, University of Sydney, Camperdown, NSW; Head of Department @ Director, Movement Disorders Unit, Department of Neurology, Westmead Hospital, Westmead, NSW.

Published: August 2022

Background: Idiopathic Parkinson's disease is a slowly progressive neurodegenerative disease. In the absence of disease-modifying therapies, patients inevitably progress to late-stage disease, characterised by a shift towards increasing disability from predominantly non-motor symptoms, which may be poorly levodopa responsive.

Objective: The aim of this article is to provide general practitioners (GPs) with a practical approach to the diagnosis and management of acute clinical deterioration in patients with late-stage Parkinson's disease. The authors outline common causes for such change and an approach to their workup and management.

Discussion: With an ageing population, we are seeing an increased prevalence of Parkinson's disease at all stages. Neurologists, geriatricians and GPs alike should therefore be familiar with the syndrome of late-stage Parkinson's disease and be equipped with treatment strategies to address acute non-motor and motor deteriorations.

Download full-text PDF

Source
http://dx.doi.org/10.31128/AJGP-03-22-6363DOI Listing

Publication Analysis

Top Keywords

parkinson's disease
20
late-stage parkinson's
12
acute clinical
8
clinical deterioration
8
deterioration patients
8
patients late-stage
8
disease
7
parkinson's
5
approach acute
4
late-stage
4

Similar Publications

Study Objectives: Deep brain stimulation (DBS) of the subthalamic nucleus (STN) may improve sleep dysfunction, a common non-motor symptom of Parkinson disease (PD). Improvement in motor symptoms correlates with DBS-suppressed local field potential (LFP) activity, particularly in the beta frequency (13 - 30 Hz). Although well-characterized in the short term, little is known about the innate progression of these oscillations across the sleep-wake cycle.

View Article and Find Full Text PDF

Background: Friedreich ataxia is a rare neurodegenerative disorder caused by frataxin deficiency. Both underweight and overweight occur in mitochondrial disorders, each with adverse health outcomes. We investigated the longitudinal evolution of anthropometric abnormalities in Friedreich ataxia and the hypothesis that both weight loss and weight gain are associated with faster disease progression.

View Article and Find Full Text PDF

: Sexual dysfunction (SD) in Parkinson's Disease (PD) patients is a common and distressing concern, although it remains an underdiagnosed and undertreated condition. Indeed, the prevalence of SD in PD ranges from 42.6% to 79% in men and from 36% to 87.

View Article and Find Full Text PDF

In the medical field, there are several very different movement disorders, such as tremors, Parkinson's disease, or Huntington's disease. A wide range of motor and non-motor symptoms characterizes them. It is evident that in the modern era, the use of smart wrist devices, such as smartwatches, wristbands, and smart bracelets is spreading among all categories of people.

View Article and Find Full Text PDF

In the context of neurodegenerative diseases, finger tapping is a gold-standard test used by clinicians to evaluate the severity of the condition. The finger tapping test involves repetitive tapping between the index finger and thumb. Subjects affected by neurodegenerative diseases, such as Parkinson's disease, often exhibit symptoms like bradykinesia, rigidity, and tremor.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!